Optimizing Colorectal Liver Metastasis Ablation through Metabolic Imaging, Margin Assessment, and Biopsy (The OPTABLATE Prospective Trial)

Comprehensive multimodal assessment of the ablation zone led to immediate onsite reablation of 14% of colorectal liver metastases after initially insufficient ablation, and local tumor control improved after thermal ablation.